Outer Retina & RPE/Bruch's Complex

Outer Retina & RPE: The En Face Disease Library

The outer retina — from the outer nuclear layer through the RPE — is where the most consequential diseases in optometric practice live: AMD, geographic atrophy, choroidal neovascularization, and outer retinal tubulations. En face imaging of this zone gives you information that B-scan simply cannot provide: the full two-dimensional extent of lesions, the spatial relationship between pathology elements, and serial change that is quantifiable and reproducible.

This module builds a systematic outer retina reading framework, from normal architecture through the major pathological signatures you will encounter in a busy practice.

Outer Retina Architecture

The outer retina has no blood supply. It is nourished entirely by the choriocapillaris through diffusion across Bruch's membrane and the RPE. This means outer retinal disease is fundamentally about the RPE-photoreceptor-Bruch's complex — when any element fails, the others follow.

On B-scan, the outer retina is identified by its characteristic hyperreflective bands:

• ELM (external limiting membrane): thin, moderately reflective band formed by zonulae adherentes between photoreceptors and Müller cells; loss of ELM signals severe outer nuclear layer dropout
• EZ (ellipsoid zone): the brightest outer retinal band; represents the densely packed mitochondria in the inner segment ellipsoid of photoreceptors; integrity of EZ is the single most important outer retinal biomarker for visual function
• IZ (interdigitation zone): represents the interdigitation of photoreceptor outer segments with RPE apical villi; less consistently visible than EZ but clinically relevant in AMD staging
• RPE: thick, highly reflective band just above Bruch's; appears as a single dense line on normal B-scan; drusen elevate it, atrophy eliminates it
• Bruch's membrane: thin line immediately below RPE; becomes visible as a distinct structure when RPE is absent (as in GA), where it persists as a faint hyperreflective remnant

RPE & Bruch's on En Face

The RPE slab is the highest-yield en face layer for AMD detection and staging. On a normal RPE en face image, you see a uniform, fine-grained gray texture — the RPE monolayer appears as a homogeneous reflectivity surface when viewed from above. The foveal region appears as a subtle dark shadow where the RPE dips with the foveal pit.

The characteristic textures on RPE en face:

Feature	En Face Appearance	Pathology
Uniform gray texture	Smooth, granular, no focal changes	Normal RPE monolayer
Bright nodules	Focal round hyper-reflective dots or mounds	Drusen (RPE elevation)
Dark patches	Focal hyporeflective areas, sharply demarcated	RPE atrophy (GA)
Bright plaques	Intensely bright, irregular shapes	Calcified drusen
Fibrovascular heterogeneity	Irregular mixed bright/dark zones	Fibrovascular PED (type 1 CNV)
Homogeneous dome	Uniformly bright elevation, smooth margins	Drusenoid PED

Reticular pseudodrusen (RPD) — also called subretinal drusenoid deposits — have a characteristic dot pattern on en face that is diagnostic when seen. They appear on the EZ slab rather than the RPE slab because they sit above the RPE in the sub-retinal space. RPD carry high conversion risk to advanced AMD and are easily missed on B-scan.

Drusen Mapping

En face RPE imaging converts the drusen burden from a qualitative assessment (scattered dots on B-scan) to a quantifiable map with area, count, and distribution data. This changes AMD staging from impression-based to metric-based.

On B-scan, drusen appear as small RPE elevations with hyperreflectivity underneath. On en face RPE slab, each drusen appears as a bright mound — the more confluent the drusen, the brighter and more diffuse the signal. The spatial arrangement of drusen on en face often reveals patterns not visible on B-scan:

• Pericentral ring: drusen clustered in a ring 1–2 disc diameters from the fovea — classic intermediate AMD pattern; fovea initially spared but at high risk
• Central mound: drusen concentrated at the foveal center — higher risk of central GA and rapid VA loss
• Diffuse scatter: drusen throughout the posterior pole with no dominant pattern — monitor all quadrants equally
• Subretinal drusenoid deposits: best visible on EZ slab, not RPE slab; appear as dot-like pattern, often in superotemporal distribution

The key clinical application of drusen mapping is AREDS2 restaging: a patient may appear to have scattered medium drusen on a foveal B-scan but confluent large drusen filling the pericentral zone on en face — a difference that changes AREDS2 category from 2 to 3 and alters your supplement recommendation.

Geographic Atrophy Boundaries

Geographic atrophy is the end-stage of dry AMD: permanent, irreversible loss of the RPE, photoreceptors, and eventually the choriocapillaris over a defined area. En face imaging defines GA boundaries with greater precision and reproducibility than any other imaging modality.

On B-scan, GA appears as choroidal hypertransmission (also called EOPR — enhanced optical penetrance of the retina) in the zone of RPE loss. On en face RPE slab, GA appears as a sharply demarcated dark area — the absence of RPE signal creates a clear void in the otherwise-uniform gray texture.

The GA boundary on en face has a characteristic appearance: the edge is abrupt, not gradual. The atrophic zone transitions directly from absent signal to normal RPE texture. Perilesional drusen often cluster at the margin of GA — these are the zones of highest near-term atrophy expansion risk.

Serial GA monitoring with en face is now the standard of care because:

• Area measurement: GA area in mm² can be calculated from en face slab at each visit; normal growth rate is approximately 1.7 mm²/year (range 0.3–3.5)
• Multifocal GA: multiple separate atrophic lesions can be individually delineated and summed; total area determines prognosis better than largest single lesion
• Foveal sparing: note whether atrophy involves the foveal center or is parafoveal; foveal-sparing GA preserves central vision for longer
• Treatment monitoring: pegcetacoplan (Syfovre) and avacincaptad pegol (Izervay) slow GA growth by approximately 35% — en face area change is the primary efficacy endpoint

Outer Retinal Tubulations

Outer retinal tubulations (ORTs) are a specific, recognizable finding in advanced dry AMD and GA. They represent collapsed and reorganized photoreceptor outer segments that form tubular structures at the outer retina–RPE interface. ORTs indicate severe, irreversible photoreceptor loss.

On B-scan, ORTs appear as round or ovoid hyporeflective spaces with a hyperreflective rim at the level of the outer retina. The internal darkness distinguishes them from drusen (which are hyperreflective internally). The key diagnostic feature is the bright annular wall with a dark center — like a hollow pipe seen in cross-section.

On en face imaging, ORTs appear as bright ring structures — the tubular walls are reflective and the inner lumen is dark, creating a distinctive annular pattern. This ring pattern is pathognomonic when seen in the context of GA or advanced AMD.

• Location: at or just above the RPE surface, within the zone of GA or perilesional outer retinal disruption
• Do not confuse with CNV: ORTs have no flow signal on OCTA; if you see bright rings on structural en face with corresponding flow on OCTA, that is CNV, not ORT
• Prognosis: presence of ORTs indicates permanent photoreceptor loss in that zone; they are stable or slowly enlarge; there is no treatment
• Serial behavior: ORTs can be tracked over time; new ORTs appearing outside the original GA boundary signal extension of the atrophic process into previously-viable retina
• Documentation: note presence, location (parafoveal, pericentral, subfoveal zone), and approximate count at each visit; this establishes whether ORTs are expanding